Three patients with malignancies (chronic myeloid leukemia, hepatoblastoma, and rhabdomyosarcoma) in this group had elevated PTHrP (13.3-55.1 pg/mL) and low PTH levels. Here, PTHLH is linked to chronic myelogenous leukemia, BCR-ABL1 positive.